Stephen Machatha
CIK: 0001836354
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (50.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ALDX
Aldeyra Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About Machatha Stephen
Machatha Stephen (SEC CIK 0001836354) files insider reports with the SEC as Chief Development Officer of Aldeyra Therapeutics, Inc. (ALDX).
Signal8 holds 2 ownership filings by Machatha Stephen, all Form 4s, filed between Mar 6, 2025 and Aug 13, 2025. Those filings report 2 transactions, from Mar 4, 2025 to Aug 11, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Machatha Stephen's filings is in LEXINGTON, MA.
Recent filings by Machatha Stephen
Other insiders filing for Aldeyra Therapeutics, Inc. (ALDX)
- Miller-Rich Nancy, Director
- DOUGLAS RICHARD, Director
- Phillips Gary M., Director
- Clark William D, Director
- Walker Neal, Director
- Bronstein Ben, Director